2,666.60
-1.15
(-0.04%)
As of 10:49:54 AM GMT+5:30. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
24,041,020
22,265,020
20,166,430
20,874,000
15,811,830
Cost of Revenue
8,123,290
7,644,290
7,291,860
5,023,000
6,015,440
Gross Profit
15,917,730
14,620,730
12,874,570
15,851,000
9,796,390
Operating Expense
10,615,000
9,952,000
9,359,930
8,480,000
6,152,490
Operating Income
5,302,730
4,668,730
3,514,640
7,371,000
3,643,900
Net Non Operating Interest Income Expense
315,710
260,710
-43,550
-302,000
278,720
Pretax Income
5,911,510
5,054,510
3,438,270
4,749,000
3,944,090
Tax Provision
1,686,580
1,431,580
1,027,500
1,246,000
979,300
Net Income Common Stockholders
4,168,350
3,577,350
2,388,480
3,448,000
2,916,210
Diluted NI Available to Com Stockholders
4,168,350
3,577,350
2,388,480
3,448,000
2,916,210
Basic EPS
50.08
43.05
28.82
41.70
35.33
Diluted EPS
50.07
43.05
28.74
41.57
35.25
Basic Average Shares
83,235.68
83,106.44
82,864.44
82,685.85
82,542.93
Diluted Average Shares
83,357.96
83,236.25
83,117.94
82,944.43
82,740.68
Rent Expense Supplemental
--
271,690
248,960
260,560
148,360
Total Expenses
18,738,290
17,596,290
16,651,790
13,503,000
12,167,930
Net Income from Continuing & Discontinued Operation
4,168,350
3,577,350
2,388,480
3,448,000
2,916,210
Normalized Income
4,094,093.13
3,502,877.41
2,411,702.35
3,448,000
2,916,427.99
Interest Income
--
554,300
331,780
472,610
438,750
Interest Expense
238,590
293,590
375,330
302,000
160,030
Net Interest Income
315,710
260,710
-43,550
-302,000
278,720
EBIT
6,150,100
5,348,100
3,813,600
5,051,000
4,104,120
EBITDA
7,571,070
6,784,070
5,315,530
6,132,000
4,876,100
Reconciled Cost of Revenue
8,123,290
7,644,290
7,291,860
5,023,000
6,015,440
Reconciled Depreciation
1,420,970
1,435,970
1,501,930
1,081,000
771,980
Net Income from Continuing Operation Net Minority Interest
4,168,350
3,577,350
2,388,480
3,448,000
2,916,210
Total Unusual Items Excluding Goodwill
103,900
103,900
-33,120
37,530
-290
Total Unusual Items
103,900
103,900
-33,120
37,530
-290
Normalized EBITDA
7,467,170
6,680,170
5,348,650
6,132,000
4,876,390
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
29,643.13
29,427.41
-9,897.65
--
-72.01
3/31/2021 - 12/23/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VIJAYA.NS Vijaya Diagnostic Centre Limited
950.40
-2.12%
METROPOLIS.NS Metropolis Healthcare Limited
1,573.85
-0.34%
SYNGENE.NS Syngene International Limited
700.45
+1.27%
METROPOLIS.BO Metropolis Healthcare Limited
1,570.75
-0.54%
KRSNAA.NS Krsnaa Diagnostics Limited
750.35
+1.38%
THYROCARE.NS Thyrocare Technologies Limited
698.70
-0.96%
SAILIFE.NS SAI LIFE SCIENCES LIMITED
661.50
+3.32%
VIMTALABS.NS Vimta Labs Limited
915.60
+7.33%
SURAKSHA.NS SURAKSHA DIAGNOSTIC LTD
275.45
-0.61%
IDHC.L Integrated Diagnostics Holdings plc
0.3600
-5.26%